US Stock MarketDetailed Quotes

VRAX Virax Biolabs

Watchlist

2.3700
+0.6700+39.41%

Close Dec 18 16:00 ET

1.9900
-0.3800-16.03%

Pre 04:47 ET

10.29MMarket Cap-0.91P/E (TTM)

Virax Biolabs Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(FY)Mar 31, 2023

(FY)Mar 31, 2022

(FY)Mar 31, 2021

(FY)Mar 31, 2020

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-49.46%-6.25M

-416.61%-4.18M

-37.09%-809.07K

20.74%-590.19K

-744.61K

Net income from continuing operations

-23.48%-6.74M

-211.90%-5.46M

-160.04%-1.75M

9.00%-672.92K

---739.46K

Operating gains losses

97.01%-8.8K

-482,513.11%-294.27K

101.58%61

-494.80%-3.87K

--981

Depreciation and amortization

--103.1K

--0

----

Other non cash items

477.52%115.5K

-93.25%20K

997.95%296.35K

-70.24%26.99K

--90.69K

Change In working capital

-514.28%-1.12M

-128.30%-182.33K

980.99%644.39K

161.57%59.61K

---96.82K

-Change in receivables

---217.84K

--0

200.00%928

---928

--0

-Change in inventory

-388.21%-60.38K

17,214.88%20.95K

100.57%121

---21.07K

--0

-Change in prepaid assets

16.03%-231.31K

-12,707.60%-275.48K

--2.19K

--0

----

-Change in payables and accrued expense

-1,785.95%-572.25K

-94.71%33.94K

685.62%641.16K

184.29%81.61K

---96.82K

-Change in other working capital

-200.00%-38.25K

--38.25K

----

Cash from discontinued investing activities

Operating cash flow

-49.46%-6.25M

-416.61%-4.18M

-37.09%-809.07K

20.74%-590.19K

---744.61K

Investing cash flow

Cash flow from continuing investing activities

-552.71%-1.16M

-178.4K

Net PPE purchase and sale

---952.5K

--0

----

Net intangibles purchase and sale

-18.81%-211.95K

---178.4K

--0

----

Cash from discontinued investing activities

Investing cash flow

-552.71%-1.16M

---178.4K

--0

----

Financing cash flow

Cash flow from continuing financing activities

-87.96%1.65M

1,583.33%13.69M

38.96%813.21K

-16.95%585.2K

704.64K

Net issuance payments of debt

-241.04%-206.27K

46.25%146.25K

--100K

--0

----

Net common stock issuance

-100.00%234

2,527.79%13.65M

--519.61K

----

Proceeds from stock option exercised by employees

--1.87M

--0

----

Net other financing activities

83.61%-18.3K

-157.67%-111.65K

-66.92%193.59K

-16.95%585.2K

--704.64K

Cash from discontinued financing activities

Financing cash flow

-87.96%1.65M

1,583.33%13.69M

38.96%813.21K

-16.95%585.2K

--704.64K

Net cash flow

Beginning cash position

42,888.32%9.35M

23.47%21.76K

-22.06%17.62K

-63.87%22.61K

--62.58K

Current changes in cash

-161.77%-5.76M

225,553.74%9.33M

182.90%4.14K

87.52%-4.99K

---39.97K

End cash Position

-61.62%3.59M

42,888.32%9.35M

23.47%21.76K

-22.06%17.62K

--22.61K

Free cash flow

-70.06%-7.41M

-438.66%-4.36M

-37.09%-809.07K

20.74%-590.19K

---744.61K

Currency Unit

USD

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Mar 31, 2024	(FY)Mar 31, 2023	(FY)Mar 31, 2022	(FY)Mar 31, 2021	(FY)Mar 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-49.46%-6.25M	-416.61%-4.18M	-37.09%-809.07K	20.74%-590.19K	-744.61K
Net income from continuing operations	-23.48%-6.74M	-211.90%-5.46M	-160.04%-1.75M	9.00%-672.92K	---739.46K
Operating gains losses	97.01%-8.8K	-482,513.11%-294.27K	101.58%61	-494.80%-3.87K	--981
Depreciation and amortization	--103.1K	--0	--0	----	----
Other non cash items	477.52%115.5K	-93.25%20K	997.95%296.35K	-70.24%26.99K	--90.69K
Change In working capital	-514.28%-1.12M	-128.30%-182.33K	980.99%644.39K	161.57%59.61K	---96.82K
-Change in receivables	---217.84K	--0	200.00%928	---928	--0
-Change in inventory	-388.21%-60.38K	17,214.88%20.95K	100.57%121	---21.07K	--0
-Change in prepaid assets	16.03%-231.31K	-12,707.60%-275.48K	--2.19K	--0	----
-Change in payables and accrued expense	-1,785.95%-572.25K	-94.71%33.94K	685.62%641.16K	184.29%81.61K	---96.82K
-Change in other working capital	-200.00%-38.25K	--38.25K	----	----	----
Cash from discontinued investing activities
Operating cash flow	-49.46%-6.25M	-416.61%-4.18M	-37.09%-809.07K	20.74%-590.19K	---744.61K
Investing cash flow
Cash flow from continuing investing activities	-552.71%-1.16M	-178.4K	0
Net PPE purchase and sale	---952.5K	--0	--0	----	----
Net intangibles purchase and sale	-18.81%-211.95K	---178.4K	--0	----	----
Cash from discontinued investing activities
Investing cash flow	-552.71%-1.16M	---178.4K	--0	----	----
Financing cash flow
Cash flow from continuing financing activities	-87.96%1.65M	1,583.33%13.69M	38.96%813.21K	-16.95%585.2K	704.64K
Net issuance payments of debt	-241.04%-206.27K	46.25%146.25K	--100K	--0	----
Net common stock issuance	-100.00%234	2,527.79%13.65M	--519.61K	----	----
Proceeds from stock option exercised by employees	--1.87M	--0	--0	----	----
Net other financing activities	83.61%-18.3K	-157.67%-111.65K	-66.92%193.59K	-16.95%585.2K	--704.64K
Cash from discontinued financing activities
Financing cash flow	-87.96%1.65M	1,583.33%13.69M	38.96%813.21K	-16.95%585.2K	--704.64K
Net cash flow
Beginning cash position	42,888.32%9.35M	23.47%21.76K	-22.06%17.62K	-63.87%22.61K	--62.58K
Current changes in cash	-161.77%-5.76M	225,553.74%9.33M	182.90%4.14K	87.52%-4.99K	---39.97K
End cash Position	-61.62%3.59M	42,888.32%9.35M	23.47%21.76K	-22.06%17.62K	--22.61K
Free cash flow	-70.06%-7.41M	-438.66%-4.36M	-37.09%-809.07K	20.74%-590.19K	---744.61K
Currency Unit	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	--	--